TabletsTablets
Schedule H (Prescription Required)Antidepressants & Mood StabilizersCode: 2125

Nortriptyline Tablets 10mg

Generic Formulation:Nortriptyline Tablets IP 10mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹9.38
Brand Estimate*
₹12.19
Estimated Savings:₹2.81 (23% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Nortriptyline Hydrochloride is a secondary amine tricyclic antidepressant and the active demethylated metabolite of amitriptyline. It selectively inhibits the reuptake of norepinephrine over serotonin, offering effective antidepressant and neuropathic analgesia with significantly less sedation, anticholinergic burden, and orthostatic hypotension than amitriptyline. Indicated for major depressive disorder and chronic neuropathic pain syndromes.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2125.Report inaccuracy

Usage Guidelines

Take orally at bedtime with water, with or without food. Titrate gradually based on clinical response and tolerability. Taper slowly when discontinuing.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Dry mouth, constipation, drowsiness, blurred vision, dizziness, tachycardia. Rare/Severe: Cardiac conduction abnormalities, myocardial infarction, seizures, bone marrow depression, and suicidality.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Boxed warning for suicidality. Contraindicated in post-myocardial infarction recovery and concurrent MAOIs. Caution in cardiovascular disorders, glaucoma, and urinary retention.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.